Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow mononuclear cells for acute middle cerebral artery ischemic stroke
2007-003700-36Phase 2Active
- Sponsor
- Unidad de Trasplantes y Terapia Celular del Hospital Universitario Central de Asturias
- Start
- Feb 2008
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, single-blind, single-arm trial of autologous bone marrow-derived mononuclear cell in ischemic stroke, sponsored by Unidad de Trasplantes y Terapia Celular del Hospital Universitario Central de Asturias. Primary endpoint: Primary efficacy endpoint. Started Feb 2008; status: active.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2007-003700-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003700-36.